Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pneumonia III: Complications and Assessment

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:

Pneumonia I: Introduction

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...

Pneumonia IV: Management

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

Pneumonia II: Pathophysiology

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:

Pneumonia V: Nursing management and Prevention

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....

Pneumothorax-I

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Chronic bronchitis - new clinical recommendations (main provisions): A review on behalf of the working group for the development and revision of clinical guidelines for chronic bronchitis].

Terapevticheskii arkhiv·2025

Same author

[New medical technologies in cough therapy: results of a double-blind randomized placebo-controlled multicenter clinical trial].

Terapevticheskii arkhiv·2024

Same author

[New clinical guidelines for COPD - a paradigm shift: A review].

Terapevticheskii arkhiv·2024

Same author

[The possibilities of impulse oscillometry in the diagnosis of the lung function disorders after COVID-19].

Terapevticheskii arkhiv·2023

Same author

[Acute bronchitis - modern possibilities of mucactive therapy].

Terapevticheskii arkhiv·2023

Same author

[Efficacy and safety of bacterial lysate OM-85 in the treatment of uncomplicated acute respiratory infections: a double-blind, placebo-controlled, multicenter, randomized trial].

Terapevticheskii arkhiv·2023

Search research articles

Related Experiment Video

Updated: Aug 24, 2025

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

["Difficult" pneumonia].

A A Zaicev¹, A I Sinopalnikov²

¹Burdenko Main Military Clinical Hospital.

Terapevticheskii Arkhiv

|October 26, 2022

Summary

This study addresses difficult pneumonia treatment, focusing on nonresolving cases. It updates diagnostic methods and antibiotic strategies for better patient outcomes, especially during the SARS-CoV-2 pandemic.

Keywords:

antibiotic therapy community-acquired pneumonia slowly resolving pneumonia “non-responding” pneumonia

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Related Experiment Videos

Last Updated: Aug 24, 2025

Experimental Model to Evaluate Resolution of Pneumonia

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Area of Science:

Pulmonology
Infectious Diseases
Critical Care Medicine

Context:

Pneumonia management presents challenges, particularly with slowly resolving or nonresolving cases.
The COVID-19 pandemic has further complicated pneumonia treatment protocols.
Identifying risk factors for treatment failure is crucial for effective patient care.

Purpose:

To analyze reasons and risk factors influencing therapeutic effectiveness in difficult pneumonia.
To update diagnostic approaches and antimicrobial therapy strategies for nonresponsive pneumonia.
To outline management tactics for pneumonia patients during the SARS-CoV-2 pandemic.

Summary:

The article examines therapeutic management for difficult pneumonia, including nonresolving cases unresponsive to initial treatment.
It analyzes risk factors, diagnostic methods, and updated antibiotic therapy guidelines.
Specific attention is given to managing pneumonia during the SARS-CoV-2 pandemic, emphasizing inflammatory markers and antimicrobial strategies.

Impact:

Provides updated clinical guidance for managing complex pneumonia cases.
Aims to improve treatment outcomes for patients with nonresolving pneumonia.
Offers insights into pneumonia management strategies during viral pandemics like COVID-19.